104 related articles for article (PubMed ID: 38713923)
1. Dysregulation of peripheral and intratumoral KLRG1
Zeng J; Zhang L; Ma S; Dai W; Xu M; Wei Y; Zhang Y; Cheng Y; Zhu G; Lu S; Li Q; Cao B
Transl Oncol; 2024 Jul; 45():101968. PubMed ID: 38713923
[TBL] [Abstract][Full Text] [Related]
2. Expression and Clinical Significance of KLRG1 and 2B4 on T Cells in the Peripheral Blood and Tumour of Patients with Cervical Cancer.
Guo Y; Feng Y; Fan P; Yao X; Peng Y; Wang R; Kuerban G
Immunol Invest; 2022 Apr; 51(3):670-687. PubMed ID: 33401997
[TBL] [Abstract][Full Text] [Related]
3. CXCR6-positive circulating mucosal-associated invariant T cells can identify patients with non-small cell lung cancer responding to anti-PD-1 immunotherapy.
Qu J; Wu B; Chen L; Wen Z; Fang L; Zheng J; Shen Q; Heng J; Zhou J; Zhou J
J Exp Clin Cancer Res; 2024 May; 43(1):134. PubMed ID: 38698468
[TBL] [Abstract][Full Text] [Related]
4. CD8
Huang B; Liu R; Wang P; Yuan Z; Yang J; Xiong H; Zhang N; Huang Q; Fu X; Sun W; Li L
J Immunother Cancer; 2020 Jun; 8(1):. PubMed ID: 32606053
[TBL] [Abstract][Full Text] [Related]
5. Expression of KLRG1 and CD127 defines distinct CD8
Wu H; Tang X; Kim HJ; Jalali S; Pritchett JC; Villasboas JC; Novak AJ; Yang ZZ; Ansell SM
J Immunother Cancer; 2021 Jul; 9(7):. PubMed ID: 34226281
[TBL] [Abstract][Full Text] [Related]
6. Short-chain fatty acids induced lung tumor cell death and increased peripheral blood CD4+ T cells in NSCLC and control patients ex vivo.
Thome CD; Tausche P; Hohenberger K; Yang Z; Krammer S; Trufa DI; Sirbu H; Schmidt J; Finotto S
Front Immunol; 2024; 15():1328263. PubMed ID: 38650948
[TBL] [Abstract][Full Text] [Related]
7. Expression of killer cell lectin-like receptor G1 on antigen-specific human CD8+ T lymphocytes during active, latent, and resolved infection and its relation with CD57.
Ibegbu CC; Xu YX; Harris W; Maggio D; Miller JD; Kourtis AP
J Immunol; 2005 May; 174(10):6088-94. PubMed ID: 15879103
[TBL] [Abstract][Full Text] [Related]
8. Expression of inhibitory "killer cell lectin-like receptor G1" identifies unique subpopulations of effector and memory CD8 T cells.
Beyersdorf NB; Ding X; Karp K; Hanke T
Eur J Immunol; 2001 Dec; 31(12):3443-52. PubMed ID: 11745363
[TBL] [Abstract][Full Text] [Related]
9. Tumor Immune Microenvironment Characteristics and Their Prognostic Value in Non-Small-Cell Lung Cancer.
Su D; Wu G; Xiong R; Sun X; Xu M; Mei Y; Wu X
Front Oncol; 2021; 11():634059. PubMed ID: 33747957
[TBL] [Abstract][Full Text] [Related]
10. Increased expression of TIGIT and KLRG1 correlates with impaired CD56
Nie Y; Liu D; Yang W; Li Y; Zhang L; Cheng X; Chen R; Yuan B; Zhang G; Wang H
Virol J; 2022 Apr; 19(1):68. PubMed ID: 35413989
[TBL] [Abstract][Full Text] [Related]
11. TGF-β downregulates KLRG1 expression in mouse and human CD8(+) T cells.
Schwartzkopff S; Woyciechowski S; Aichele U; Flecken T; Zhang N; Thimme R; Pircher H
Eur J Immunol; 2015 Aug; 45(8):2212-7. PubMed ID: 26014037
[TBL] [Abstract][Full Text] [Related]
12. Expanded CD8+ T cells of murine and human CLL are driven into a senescent KLRG1+ effector memory phenotype.
Göthert JR; Eisele L; Klein-Hitpass L; Weber S; Zesewitz ML; Sellmann L; Röth A; Pircher H; Dührsen U; Dürig J
Cancer Immunol Immunother; 2013 Nov; 62(11):1697-1709. PubMed ID: 24022692
[TBL] [Abstract][Full Text] [Related]
13. Differential regulation of killer cell lectin-like receptor G1 expression on T cells.
Robbins SH; Terrizzi SC; Sydora BC; Mikayama T; Brossay L
J Immunol; 2003 Jun; 170(12):5876-85. PubMed ID: 12794113
[TBL] [Abstract][Full Text] [Related]
14. Circular RNA circ-CPA4/ let-7 miRNA/PD-L1 axis regulates cell growth, stemness, drug resistance and immune evasion in non-small cell lung cancer (NSCLC).
Hong W; Xue M; Jiang J; Zhang Y; Gao X
J Exp Clin Cancer Res; 2020 Aug; 39(1):149. PubMed ID: 32746878
[TBL] [Abstract][Full Text] [Related]
15. Functions and clinical significance of KLRG1 in the development of lung adenocarcinoma and immunotherapy.
Yang X; Zheng Y; Han Z; Zhang X
BMC Cancer; 2021 Jun; 21(1):752. PubMed ID: 34187403
[TBL] [Abstract][Full Text] [Related]
16. Frequent expression of the natural killer cell receptor KLRG1 in human cord blood T cells: correlation with replicative history.
Marcolino I; Przybylski GK; Koschella M; Schmidt CA; Voehringer D; Schlesier M; Pircher H
Eur J Immunol; 2004 Oct; 34(10):2672-80. PubMed ID: 15368283
[TBL] [Abstract][Full Text] [Related]
17. Lack of proliferative capacity of human effector and memory T cells expressing killer cell lectinlike receptor G1 (KLRG1).
Voehringer D; Koschella M; Pircher H
Blood; 2002 Nov; 100(10):3698-702. PubMed ID: 12393723
[TBL] [Abstract][Full Text] [Related]
18. PD-1 blockade potentiates neoadjuvant chemotherapy in NSCLC via increasing CD127
Hui Z; Ren Y; Zhang D; Chen Y; Yu W; Cao J; Liu L; Wang T; Xiao S; Zheng L; Pu Y; Wei F; You J; Ren X
NPJ Precis Oncol; 2023 May; 7(1):48. PubMed ID: 37231145
[TBL] [Abstract][Full Text] [Related]
19. Contribution of pulmonary KLRG1(high) and KLRG1(low) CD8 T cells to effector and memory responses during influenza virus infection.
Ye F; Turner J; Flaño E
J Immunol; 2012 Dec; 189(11):5206-11. PubMed ID: 23089397
[TBL] [Abstract][Full Text] [Related]
20. ILT4 inhibition prevents TAM- and dysfunctional T cell-mediated immunosuppression and enhances the efficacy of anti-PD-L1 therapy in NSCLC with EGFR activation.
Chen X; Gao A; Zhang F; Yang Z; Wang S; Fang Y; Li J; Wang J; Shi W; Wang L; Zheng Y; Sun Y
Theranostics; 2021; 11(7):3392-3416. PubMed ID: 33537094
[No Abstract] [Full Text] [Related]
[Next] [New Search]
